MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male

B. Akkineni, L. Teshome, E. Krause (Austin, USA)

Meeting: 2025 International Congress

Keywords: Parkinsonism, Spasticity: Genetics, Tremors: Genetics

Category: Parkinsonism (Other)

Objective: N/a

Background: Less than a hundred cases of mitochondrial membrane protein-associated neurodegeneration (MPAN) have been reported thus far in literature. We present a case of a young patient who presented with atypical parkinsonian features, including a severe high amplitude tremor in proximal and distal extremities, which led to an initial diagnosis of functional neurological disorder. He was later found to have a C19orf12 mutation associated with MPAN, a subtype of neurodegeneration with brain iron accumulation (NBIA). Many reported MPAN cases presented with similar phenotypes including dystonia, optic atrophy, dysarthria, rapidly progressive parkinsonism, neuropsychiatric abnormalities, and cognitive decline – though in our case, the severity of his parkinsonian symptoms is distinctive.

A 29-year-old male with a history of depression, anxiety, premature birth, and intellectual disability presented for evaluation of a progressively worsening tremor for years. The tremor first started in his left leg then spread to his right leg and bilateral hands. He also had falls and was reliant on a rollator. On initial exam, he had bilateral upper and lower extremity tremors at varied frequencies and amplitudes with a distractible quality, diaphoresis, spasticity with left foot dystonic posturing, and a glabellar reflex. Several medications were tried, including propranolol, primidone, gabapentin, topiramate, carbidopa/levodopa with no symptomatic improvement. The workup included an MRI brain and 48-hr ambulatory EEG, which were unremarkable, and he was consequently diagnosed with functional neurological disorder. Repeat exam by a movement disorder specialist identified masked facies, rigidity in extremities, grade 3-4 resting tremor, and shuffling gait, which prompted a diagnosis of parkinsonism. He continued to have limited response to carbidopa/levodopa. Given his age, genetic testing was obtained, which demonstrated a heterozygous mutation in the C19orf12 gene associated with MPAN.

Many known MPAN cases, regardless of their inheritance pattern, presented with similar phenotypes including parkinsonism as seen in our case. Due to his young age and diffuse tremors with high amplitudes and frequencies, he was misdiagnosed with functional neurological disorder. Our case spotlights a very rare disease and the challenges of diagnosing it.

Method: N/a

Results: N/a

Conclusion: N/a

To cite this abstract in AMA style:

B. Akkineni, L. Teshome, E. Krause. A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-case-of-mitochondrial-membraine-protein-associated-neurodegeneration-with-progressive-parkinsonism-in-a-young-male/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-case-of-mitochondrial-membraine-protein-associated-neurodegeneration-with-progressive-parkinsonism-in-a-young-male/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley